Recently, various executives have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Twitter Inc (NYSE:TWTR), and Novavax, Inc. (NASDAQ:NVAX).
Gilead Sciences, Inc.
President and COO John F. Milligan disposed 100,000 Gilead Sciences shares (8.86% of total stake), valued at $11,404,678, in two transactions dated June 8. Milligan now holds 1,029,108 of the company’s shares that are valued at $122,597,636.
Director Evan Clark Williams sold 372,000 Twitter shares valued at $13,356,541, in multiple transactions dated June 9 to 10. The shares were sold via automatic sale program. Williams now holds 2,829,196 of the company’s shares.
Intercept Pharmaceuticals Inc
CSO Luciano Adorini unloaded 4,000 Intercept Pharmaceuticals shares, valued at $993,580, in two transactions dated June 8. The shares were sold via automatic sale program. Adorini now holds 10,060 of the company’s shares that are valued at $2,493,170.
Director Rajiv Modi dumped 551,081 Novavax shares (15.77% of total stake), valued at $4,944,943, in three transactions dated June 8 to 10. Modi now holds 2,944,238 of the company’s shares that are valued at $26,468,700.